MAM
BLFS icon

Meeder Asset Management’s BioLife Solutions BLFS Stock Holding History

Meeder Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-246
Closed -$6K – 932
2022
Q3 		$6K Buy
246
+58
+31% +$1.24K ﹤0.01% 1489
2022
Q2 		$3K Sell
188
-30
-14% -$440 ﹤0.01% 1774
2022
Q1 		$5K Buy
218
+147
+207% +$3.87K ﹤0.01% 1775
2021
Q4 		$3K Buy
71
+21
+42% +$901 ﹤0.01% 922
2021
Q3 		$2K Buy
+50
New +$2.41K ﹤0.01% 2163

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Meeder Asset Management's BLFS Position: Q4 2022 in Review

Meeder Asset Management sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 246 shares — an estimated $6K sold.

Meeder Asset Management first reported a position in BLFS in Q3 2021 and held it in 5 quarters. The position peaked at $6K in Q3 2022. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

  • Meeder Asset Management reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 246 BioLife Solutions shares in Q4 2022, an estimated $6K.
  • Meeder Asset Management first reported a position in BioLife Solutions in Q3 2021 and held it in 5 quarters.
  • Meeder Asset Management's BioLife Solutions position peaked at $6K in Q3 2022.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.